Abstract
The activation of cell cycle checkpoints in response to genotoxic stressors is essential for the maintenance of genomic integrity. Although most prior studies of cell cycle effects of UV irradiation have used UVC, this UV range does not penetrate the earth's atmosphere. Thus, we have investigated the mechanisms of ultraviolet B (UVB) irradiation-induced cell cycle arrest in a biologically relevant target cell type, the early stage human melanoma cell line, WM35. Irradiation of WM35 cells with UVB resulted in arrests throughout the cell cycle: at the G1/S transition, in S phase and in G2. G1 arrest was accompanied by increased association of p21 with cyclin E/cdk2 and cyclin A/cdk2, increased binding of p27 to cyclin E/cdk2 and inhibition of these kinases. A loss of Cdc25A expression was associated with an increased inhibitory phosphotyrosine content of cyclin E- and cyclin A-associated cdk2 and may also contribute to G1 arrest following UVB irradiation. The association of Cdc25A with 14-3-3 was increased by UVB. Reduced cyclin D1 protein and increased binding of p21 and p27 to cyclin D1/cdk4 complexes were also observed. The loss of cyclin D1 could not be attributed to inhibition of either MAPK or PI3K/PKB pathways, since both were activated by UVB. Cdc25B levels fell and the remaining protein showed an increased association with 14-3-3 in response to UVB. Losses in cyclin B1 expression and an increased binding of p21 to cyclin B1/cdk1 complexes also contributed to inhibition of this kinase activity, and G2/M arrest.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alblas J, Slager-Davidov R, Seenbergh PH, Sussenbach JS and van der Burg B. . 1998 Oncogene 16: 131–139.
Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P and Hemmings BA. . 1996 EMBO J. 15: 6541–6551.
Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB and Cohen P. . 1997 Curr. Biol. 7: 261–269.
Baldin V, Lukas J, Marcote MJ, Pagano M and Draetta G. . 1993 Genes Dev. 7: 812–821.
Barker D, Dixon K, Medrano EE, Smalara D, Im S, Mitchell D, Babcock G and Abdel-Malek ZA. . 1995 Cancer Res. 55: 4041–4046.
Blasina A, Paegle ES and McGowan CH. . 1997 Mol. Biol. Cell 8: 1013–1023.
Chen J, Jackson PK, Kirschner MW and Dutta A. . 1995 Nature 374: 386–388.
Chen J, Peters R, Saha P, Lee P, Theodoras A, Pagano M, Wagner G and Dutta A. . 1996 Nucleic. Acids. Res. 24: 1727–1733.
Cheng M, Sexl V, Sherr CJ and Roussel MF. . 1998 Proc. Natl. Acad. Sci. USA 95: 1091–1096.
Diehl JA, Cheng M, Roussel MF and Sherr CJ. . 1998 Genes Dev. 12: 3499–3511.
Diehl JA, Zindy F and Sherr CJ. . 1997 Genes Dev. 11: 957–972.
Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A and Weinberg RA. . 1993 Cell 73: 499–511.
Draetta G and Eckstein J. . 1997 Biochim. Biophys. Acta 1332: M53–M63.
Dulic V, Lees E and Reed SI. . 1992 Science 257: 1958–1961.
El-Deiry WS, Tokino T, Velculescu VE, Levy D, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. . 1993 Cell 75: 817–825.
Elledge SJ. . 1996 Science 274: 1664–1672.
Enoch T and Nurse P. . 1990 Cell 60: 665–673.
Epstein JH. . 1983 J. Am. Acad. Dermatol. 9: 487–502.
Ewen ME, Slus HK, Sherr CJ, Matsushime H, Kato J-Y and Livingston DM. . 1993 Cell 73: 487–497.
Fang F and Newport J. . 1991 Cell 66: 731–742.
Florenes VA, Bhattacharya N, Bani MR, Ben-David J, Kerbel RS and Slingerland JM. . 1996 Oncogene 13: 2447–2457.
Flores-Rosas H, Kelman Z, Dean FB, Pan Z, Harper JW, Elledge SJ, O'Donnell M and Hurwitz J. . 1994 Proc. Natl. Acad. Sci. USA 91: 8655–8659.
Furnari B, Rhind N and Russell P. . 1997 Science 277: 1495–1497.
Gabrielli BG, Clark JM, McCormack AK and Ellem KA. . 1997 Oncogene 15: 749–758.
Giordano A, Whyte P, Harlow E, Franza Jr BR, Beach D and Draetta G. . 1989 Cell. 58: 981–990.
Girard F, Strausfeld U, Fernandez A and Lamb N. . 1991 Cell. 67: 1169–1179.
Gould K and Nurse P. . 1989 Nature 342: 39–45.
Gu Y, Rosenblatt J and Morgan DO. . 1992 EMBO J. 11: 3995–4005.
Hartwell L. . 1992 Cell. 71: 543–546.
Hartwell LH and Kastan MB. . 1994 Science 266: 1821–1828.
Hartwell LH and Weinert TA. . 1989 Science 246: 629–634.
Herzinger T, Funk JO, Hillmer K, Eick D, Wolf DA and Kind P. . 1995 Oncogene 11: 2151–2156.
Hoffmann I, Draetta G and Karsenti E. . 1994 EMBO J. 13: 4302–4310.
Hunter T. . 1995 Cell. 80: 225–236.
Jin P, Gu Y and Morgan DO. . 1996 J. Cell Biol. 134: 963–970.
Jinno S, Suto K, Nagata A, Igarashi M, Kanaoka Y, Nojima H and Okayama H. . 1994 EMBO J. 13: 1549–1556.
Kastan MB, Zhan Q, El-Deiry W, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace AJ. . 1992 Cell. 71: 587–597.
Kato J-Y, Matsushime H, Hiebert SW, Ewen ME and Sherr CJ. . 1993 Genes Dev. 7: 331–342.
Kaufmann WK, Boyer JC, Estabrooks LL and Wilson SJ. . 1991 Mol. Cell. Biol. 11: 3771–3718.
Krek W and Nigg E. . 1991 EMBO J. 10: 305–316.
Kumagai A and Dunphy WG. . 1999 Genes Dev. 13: 1067–1072.
LaBaer J, Garrret M, Steenson M, Slingerland J, Sandhu C, Chou H, Fattaey A and Harlow H. . 1997 Genes Dev. 11: 847–862.
Lau CC and Pardee AB. . 1994 Proc. Natl. Acad. Sci. USA. 79: 7491–7495.
Lew DJ and Kornbluth S. . 1996 Curr. Opin. Cell Biol. 8: 795–804.
Li JJL and Deshaies RJ. . 1993 Cell. 74: 223–226.
Liu M, Dhanwada KR, Birt D, Hecht S and Pelling D. . 1994 Carcinogenesis 15: 1089–1092.
Liu M and Pelling JC. . 1995 Oncogene 10: 1955–1960.
Lopez-Girona A, Furnari B, Mondesert O and Russell P. . 1999 Nature 397: 172–175.
Lu X and Lane DP. . 1993 Cell 75: 765–778.
McGowan CH and Russell P. . 1995 EMBO J. 14: 2166–2175.
Meyerson M and Harlow E. . 1994 Mol. Cell. Biol. 14: 2077–2086.
Morgan DO. . 1995 Nature 374: 131–134.
Muise-Helmericks RC, Grimes HL, Bellacosa A, Malstrom SE, Tsichlis PN and Rosen N. . 1998 J. Biol. Chem. 273: 29864–29872.
Muller H, Lukas J, Schneider A, Warthoe P, Bartek J, Eilers M and Srauss M. . 1994 Proc. Natl. Acad. Sci. USA 91: 2945–2949.
O'Connor PM, Ferris DK, Hoffmann I, Jackman J, Draetta G and Kohn KW. . 1994 Proc. Natl. Acad. Sci. USA 91: 9480–9484.
Ogryzko VV, Wong P and Howard BH. . 1997 Mol. Cell. Biol. 17: 4877–4882.
Pagano M, Pepperkok R, Verde F, Ansorge W and Draetta G. . 1992 EMBO J. 11: 961–971.
Pagano M, Theodoras AM, Tam SW and Draetta G. . 1994 Genes Dev. 8: 1627–1639.
Parker LL, Sylvestre PJ, Byrnes MJ3, Liu F and Piwnica-Worms H. . 1995 Proc. Natl. Acad. Sci. USA 92: 9638–9642.
Paulovich AG, Toczyski DP and Hartwell LH. . 1997 Cell. 88: 315–321.
Payne DM, Rossomando AJ, Martino P, Erickson AK, Her JH, Shabanowitz J, Hunt DF, Weber MJ and Sturgill TW. . 1991 EMBO J. 10: 885–892.
Pedley J, Ablett EM, Pettit A, Meyer J, Dunn IS, Sturm RA and Parsns PG. . 1996 Oncogene 13: 1335–1342.
Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS and Piwnica-Worms H. . 1997 Science 277: 1501–1505.
Petrocelli T, Poon R, Drucker D, Slingerland J and Rosen C. . 1996 Oncogene 12: 1387–1396.
Poon R, Toyoshima H and Hunter T. . 1995 Mol. Biol. Cell. 6: 1197–1213.
Poon RYC, Jiang W, Toyoshima H and Hunter T. . 1996 J. Biol. Chem. 271: 13283–13291.
Reed SI, Bailly E, Dulic V, Hengst L, Resnitzky D and Slingerland J. . 1994 J. Cell. Sci. Supplement 18: 69–73.
Rhind N, Furnari B and Russell P. . 1997 Genes Dev. 11: 504–511.
Rigel DS, Friedman RJ and Kopf AW. . 1996 J. Am. Acad. Dermatol. 35: 1012–1013.
Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H and Elledge SJ. . 1997 Science 277: 1497–1501.
Shaw M, Cohen P and Alessi DR. . 1997 FEBS Lett. 416: 307–311.
Sherr CJ. . 1994 Cell. 79: 551–555.
Sherr CJ and Roberts JM. . 1995 Genes Dev. 9: 1149–1163.
Sherr CJ and Roberts JM. . 1999 Genes Dev. 13: 1501–1512.
Slingerland JM, Hengst L, Pan C-H, Alexander D, Stampfer MR and Reed SI. . 1994 Mol. Cell. Biol. 14: 3683–3694.
Solomon MJ. and Kaldis P. . 1998 Results Probl. Cell Differ. 22: 79–109.
Sutherland C, Leighton IA and Cohen P. . 1993 Biochem. J. 296: 15–19.
Terada Y, Tatsuka M, Jinno S and Okayama H. . 1995 Nature 376: 358–362.
Waga S, Hannon GJ, Beach D and Stillman B. . 1994 Nature 369: 574–578.
Wang XQ and Ellem KA. . 1994 Exp. Cell. Res. 212: 176–189.
Yang J, Winkler K, Yoshida M and Kornbluth S. . 1999 EMBO J. 18: 2174–2183.
Zimmermann S and Moelling K. . 1999 Science 286: 1741–1744.
Acknowledgements
JM Slingerland is a clinician investigator supported by Cancer Care Ontario, and by a career awards from the US Army Department of Defense Breast Cancer Research Program and from the Burroughs Wellcome Fund. We thank Dr N Bhattacharya for excellent technical assistance with tissue culture and irradiation of cells. This work was supported by grants to JM Slingerland from the CBCRI/National Cancer Institute of Canada.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Petrocelli, T., Slingerland, J. UVB induced cell cycle checkpoints in an early stage human melanoma line, WM35. Oncogene 19, 4480–4490 (2000). https://doi.org/10.1038/sj.onc.1203808
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203808
Keywords
This article is cited by
-
Photosensitized mefloquine induces ROS-mediated DNA damage and apoptosis in keratinocytes under ambient UVB and sunlight exposure
Cell Biology and Toxicology (2014)
-
Transcriptional increase and misexpression of 14-3-3 epsilon in sea urchin embryos exposed to UV-B
Cell Stress and Chaperones (2010)
-
Upregulation of p27 and its inhibition of CDK2/cyclin E activity following DNA damage by a novel platinum agent are dependent on the expression of p21
British Journal of Cancer (2006)
-
Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B-mediated responses by resveratrol in SKH-1 hairless mouse skin
Oncogene (2004)
-
ΔMEKK3:ER* activation induces a p38α/β2-dependent cell cycle arrest at the G2 checkpoint
Oncogene (2002)